IRIS
DAMIANI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.670
EU - Europa 4.416
AS - Asia 2.254
SA - Sud America 433
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 4
Totale 20.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.541
UA - Ucraina 1.533
SG - Singapore 1.159
DE - Germania 688
CN - Cina 611
FI - Finlandia 521
IT - Italia 431
BR - Brasile 395
RU - Federazione Russa 355
SE - Svezia 302
IE - Irlanda 243
KR - Corea 157
TR - Turchia 126
FR - Francia 116
CA - Canada 107
GB - Regno Unito 84
IN - India 46
IR - Iran 29
VN - Vietnam 29
CZ - Repubblica Ceca 23
HK - Hong Kong 19
BE - Belgio 17
CO - Colombia 15
NL - Olanda 15
AT - Austria 14
PL - Polonia 14
EU - Europa 13
MX - Messico 13
TG - Togo 11
UZ - Uzbekistan 10
RO - Romania 9
BD - Bangladesh 8
IQ - Iraq 8
JP - Giappone 8
AR - Argentina 7
EG - Egitto 7
ES - Italia 7
RS - Serbia 7
ZA - Sudafrica 7
BG - Bulgaria 6
AZ - Azerbaigian 5
PK - Pakistan 5
CH - Svizzera 4
EC - Ecuador 4
KG - Kirghizistan 4
MA - Marocco 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
GR - Grecia 3
HU - Ungheria 3
ID - Indonesia 3
IL - Israele 3
JO - Giordania 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
GL - Groenlandia 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
PY - Paraguay 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MK - Macedonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
QA - Qatar 1
TT - Trinidad e Tobago 1
Totale 20.823
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.113
Ann Arbor 1.688
Fairfield 1.222
Houston 1.176
Jacksonville 1.104
Chandler 762
Singapore 673
Dearborn 590
Ashburn 562
Wilmington 505
Seattle 443
Cambridge 374
Beijing 314
Boardman 301
Princeton 252
Dublin 242
Seoul 146
Izmir 110
Udine 110
San Diego 102
Ottawa 77
Ogden 62
Norwalk 56
Dallas 44
Hefei 41
Trieste 40
Des Moines 39
Los Angeles 39
Munich 37
New York 37
Nanjing 35
São Paulo 31
Regensburg 29
Santa Clara 29
Kunming 28
Helsinki 27
Dong Ket 25
Guangzhou 21
Hong Kong 19
Simi Valley 19
Toronto 19
Augusta 18
Turku 18
Brussels 17
Jinan 16
Phoenix 16
Andover 15
Washington 15
Leawood 14
Nanchang 14
Warsaw 14
Rio de Janeiro 13
Rome 13
Bogotá 12
Milan 12
San Mateo 12
Brasília 11
Fuzhou 11
Lomé 11
Monmouth Junction 11
Belo Horizonte 10
Brno 10
San Francisco 10
Grafing 9
Tashkent 9
Vienna 9
Zanjan 9
Duino-Aurisina 8
Hebei 8
Montreal 8
Mumbai 8
Wuhan 8
Ardabil 7
Boston 7
Brooklyn 7
Düsseldorf 7
Frankfurt am Main 7
Lauterbourg 7
Olomouc 7
Porto Alegre 7
Tokyo 7
Venice 7
Belgrade 6
Cairo 6
Curitiba 6
Horia 6
Istanbul 6
Mexico City 6
Redwood City 6
Saint Petersburg 6
Shenyang 6
São Bernardo do Campo 6
Caxias do Sul 5
Hangzhou 5
Hyderabad 5
Johannesburg 5
London 5
Maceió 5
Ningbo 5
Nuremberg 5
Totale 14.082
Salva come PNG Salva come JPEG
Nome #
Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy 245
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 192
“Fibre nervose peptidergiche intraepidermiche: uno studio immunoistochimico”. 161
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 159
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non MDR cells to different anthracycline derivatives 157
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 152
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 140
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 139
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 139
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells 138
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 135
Histone post-translational modifications associated to BAALC expression in leukemic cells. 134
Clinical feature and outcome in seven patients wuth hyaline or mixed variant of Castleman’s disease. A single centre experience 133
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 129
ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission 128
“Overexpression of multidrug resistance-associated P-170 glycoprotein in acute non lymphocytic leukemia”. 127
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome 124
P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia. 123
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 122
Autologous stem cell transplantation in chronic carriers of hepatitis B virus and hepatitis C virus affected by onco-hematologic diseases. 122
Autologus stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcome. 120
Granulocyte-macrophage colony -stimulating factor in acute nonlymphocytic leukemia before and after chemo therapy”. 120
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia 120
Longitudinal follow-up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogeneic bone marrow transplant 119
ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia 119
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. 117
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 116
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias 116
Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement 116
Multipotent Mesenchymal Stem Cells Can Be Isolated and Grown from Many Tissues (Bone Marrow, Liver and Heart) 116
“Long Term Follow-up of the Italian Trial of Interferon-a Versus Conventional Chemotherapy in Chronic Myeloid Leukemia”. 115
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia 115
Visualization of PGP 9.5 immunoreactive nerve terminals in the mouse snout epidermis. 115
Unexpected phenotype of a typical NPM1 mutant 113
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML 113
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance 113
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 112
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine 112
“Espressione dell’antigene CD34 nei tessuti normali e patologici e possibili applicazioni cliniche delle cellule CD34”. 111
“D-Verapamil downmodulates P-170 associated resistance to doxorubicin, daunorubicin and idarubicin”. 111
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 111
Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera. 111
Acute promyelocytic leucemia: low expression of multidrug resistance phenotype at onset suggest a favourable effect of gentuzumab ozogamicyn (CMA-676 110
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 years treated with induction regimens including fludarabine: retrospective analysis of 224 cases 110
CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis”. 109
Suggestive evidence for a Microanatomical Relationship betweeb Mast Cells and Nerve Fibres Containing Substance P, Calcitonin Gene Related Peptide, Vasoactive Intestinal Polypeptide, and Somatostatin in the rat Mesentery. 109
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype 109
Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia. 109
Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression 109
Flow cytometry evaluation of plasma cells contaminating leukapheresis pre- and post- CD34-positive selection- 108
“CD34+ selected versus un-manipulated autologous stem cell transplantation in multiple myeoloma: impact on dendritic and immune recovery and on complications due to infections”. 108
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients 108
“Case report: mdr-1 gene amplification in acute lymphoblastic leukemia prior to antileukemic treatment”. 108
A mutational status of IGVH genes consisten with antigen-driven selection has prognostic impact istead of percento f mutations in B-cell chronic lymphocytic leukemia 107
Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow) 107
FEASIBILITY OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH CD34 SELECTED STEM CELLS: OUTCOME AND IMMUNOLOGICAL COMPLICATIONS 106
Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy. 106
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 105
A study of the material in the ATLAS inner detector using secondary hadronic interactions 105
Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma 103
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 103
Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells. 102
KERATOCONJUNCTIVITIS TREATMENT WITH AUTOLOGOUS SERUM EYE IN PATIENTS WITH SEVERE CHRONIC GVHD 102
5-AZACITIDINE FIVE DAYS/MONTHLY SCHEDULE IN SYMPTOMATIC LOW-RISK (IPSS: 0-1) MYELODISPLASTIC (MDS) PATIENTS. CLINICAL AND BIOLOGICAL EFFECTS Authors 102
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 102
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 101
Cytokines dysregulation and chronic graft versus host disease after allogeneic haematopoieitc stem cell transplantation with reduced intensity conditioning 100
“Expression of Multidrug resistance gene (MDR 1) in normal hematopoietic cells”. 100
Peripheral blood stem cell mobilization in multiple myeloma: advantage of 7 vs. 4 g/m2 cyclophosfamide on stem cell quality and plasma cell mobilization. 99
Dendritic cell recovery after autologous stem cell transplantation 99
Proliferation and maturation effects of in vivo granulo-monocyte colony stimulating factor in acute non-lymphocytic leucemia”. 98
DENDRITIC CELL RECOVERY AFTER AUTOLOGOUS AND ALLOGENEIC TRANSPLANTATION 98
KIR POLYMORPHISM IN REDUCED INTENSITY HLA-ID SIBLING STEM CELL TRANSPLANTATION: IMPACT ON CLINICAL OUTCOME 98
Serotoninergic fibres form dense synaptic contacts with Purkinje cells in the mouse cerebellar cortex--an immunohistochemical study 98
The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia. 97
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. 97
Acute promyelocyttic leucemia: low expression of multidrug resistance phenotype at onset suggests a favorable effect of Gemtuzumab Ozogamycin (CMA 676) 96
A simple Prognostic Scoring System for newly diagnosed acute leukaemia patients with normal karyotype: a retrospective analysis on 173 cases. 96
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation 95
“Treatment of Ph+ chronic myeloid leukemia by gamma interferon”. 95
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy. 94
Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis 94
Isolation, characterization and in vitro growth of human multipotent adult cardiac progenitor cells 93
Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemia. 92
Improvement of amyloid-related symptoms after autologous stem cell transplantation in a patient with hepatomegaly, macroglossia and purpura 92
FEASIBILITY AND OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OLDER THAN 60 YEARS WITH POOR RISK ACUTE MYELOID LEUKEMIA 92
Effect of fludarabine and arabinosylcytosine on multidrug resistant cells. 91
“Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas”. 91
Sequential study of cytokine and lymphocyte patterns in patients with chronic agraft versus host disease after reduced intensity conditioning allogenic stem cell transplantation 90
The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leucemia 90
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias 89
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) in de novo adult acute lymphoblastica leukemia 89
Fludarabine, Arabynosil cytosine and Idarubicin (FLAI), a combination of non MDR related drugs for tratment of patients with newly diagnosed acute myeloi leukemia. 89
Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia 88
ABCB1 (PGP) and ABCG (BCRP) proteins are independent prognostic factors for complete remissione and relapse risk, respectively in normal karyotype adult de novo acute myeloid leukemia. 88
Allogeneic stem cell transplantation as salvage therapy for patients with lymphoma. 87
Treatment intensification of malignant lymphomas with autologous bone marrow transplantation and granulocyte colony stimulating factor. 87
“Multidrug resistance (MDR1) in acute myelogenous leukemia: is it time to test?” 86
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults. 86
Invasive fungal infections in allogneic haematopoietic stem cell transplantation: 12 years experience on 246 patients at a single institution 86
Totale 11.138
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.666
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020484 0 0 0 0 0 0 0 0 0 0 116 368
2020/20212.774 44 309 21 364 71 404 154 343 493 68 414 89
2021/20221.898 53 276 69 167 64 47 78 103 19 311 396 315
2022/20231.861 273 97 16 226 188 519 6 149 254 31 57 45
2023/2024600 98 58 35 27 71 84 10 33 86 44 13 41
2024/20253.093 87 346 209 117 140 187 262 285 476 247 737 0
Totale 21.169